COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 304.1 | 7 | 0112-0393 | 388.35 | 393.40 | 457 | 80.91 | 0.877 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 292.6 | 7 | 0113-0401 | 715.27 | 400.99 | 439 | 83.74 | 0.787 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 253.6 | 7 | 0114-0401 | 910.08 | 400.87 | 410 | 77.26 | 0.863 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 266.2 | 7 | 0115-0402 | 80.39 | 401.50 | 410 | 78.08 | 0.845 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 246.6 | 7 | 0116-0408 | 115.91 | 409.20 | 851 | 116.95 | 0.782 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 319.8 | 7 | 0117-0406 | 47.71 | 407.15 | 428 | 79.60 | 0.849 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 222.7 | 7 | 0118-0417 | 672.49 | 417.03 | 472 | 85.50 | 0.811 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 330.6 | 7 | 0119-0419 | 258.24 | 419.29 | 418 | 75.26 | 0.928 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 278.8 | 7 | 0120-0419 | 852.42 | 418.87 | 438 | 77.84 | 0.908 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 285.8 | 7 | 0121-0422 | 462.95 | 422.00 | 463 | 84.57 | 0.814 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1059.2 | 7 | 0122-0428 | 737.20 | 428.53 | 799 | 106.23 | 0.890 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 239.9 | 7 | 0123-0426 | 357.00 | 426.46 | 420 | 78.91 | 0.848 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 237.9 | 7 | 0124-0433 | 207.82 | 432.94 | 401 | 76.67 | 0.857 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 264.7 | 7 | 0125-0439 | 548.38 | 439.23 | 853 | 114.71 | 0.815 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 236.3 | 7 | 0126-0445 | 130.87 | 445.13 | 436 | 81.15 | 0.832 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 246.8 | 7 | 0127-0446 | 872.69 | 446.15 | 435 | 79.50 | 0.865 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 265.7 | 7 | 0128-0450 | 177.60 | 449.89 | 471 | 86.57 | 0.790 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 456.8 | 7 | 0129-0458 | 504.55 | 457.94 | 831 | 112.13 | 0.831 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 296.3 | 7 | 0130-0453 | 617.91 | 452.19 | 430 | 79.98 | 0.845 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 765.5 | 7 | 0131-0460 | 330.60 | 460.23 | 433 | 78.08 | 0.892 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 267.4 | 7 | 0132-0469 | 633.26 | 470.21 | 488 | 85.40 | 0.841 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 296.9 | 7 | 0133-0468 | 685.96 | 468.34 | 437 | 78.91 | 0.882 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 248.3 | 7 | 0134-0469 | 439.37 | 469.24 | 443 | 79.84 | 0.873 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 406.1 | 7 | 0135-0469 | 568.45 | 470.06 | 280 | 84.08 | 0.498 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1076.7 | 7 | 0136-0482 | 928.02 | 481.95 | 894 | 116.95 | 0.821 |